1,000
Participants
Start Date
July 13, 2023
Primary Completion Date
June 1, 2025
Study Completion Date
June 1, 2026
84-gene penal
84-gene penal was targeted sequenced in 1000 PTCL patients to investigate their mutation profile and molecular subtypes.
RECRUITING
Peking University People's Hospital, Beijing
RECRUITING
Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITING
Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing
RECRUITING
Henan Cancer Hospital, Henan
NOT_YET_RECRUITING
Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China, Shandong
RECRUITING
Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Sichuan
West China Hospital
OTHER
Shandong Provincial Hospital
OTHER_GOV
RenJi Hospital
OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Ruijin Hospital
OTHER